ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR Convergence 2026

Abstract Number: 0772

Medication Adherence in an Urban Safety-Net Rheumatology Clinic: Associations with Social Determinants and Clinical Factors

Valeria Esparza1, Negin Samandari2, Parmida Zandinejad3, Mohamed Elbathani1, Ana Leal Bramasco1, Trevor Pickering4 and Leanna Wise5

Affiliations: 1LAGMC/Keck Medicine of USC, Los Angeles, CA, 2Keck School of Medicine of USC, Los Angeles, CA, 3Herman Ostrow School of Dentistry, Los Angeles, 4University of Southern California, Los Angeles, 5LAGMC/Keck Medicine of USC, Pasadena, CA

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR Convergence 2026

Keywords: Access to care, Minority Health, risk factors, socioeconomic factors, Surveys

Session Information

Date: Sunday, November 8, 2026

Title: (0764-0778) Healthcare Disparities in Rheumatology Poster A

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Medication adherence is essential for effective management of chronic rheumatic diseases (RMDs). Patient and disease characteristics, along with social determinants of health (SDOH), can influence adherence behaviors. However, their contributions to intentional and unintentional nonadherence remain incompletely understood. We evaluated factors associated with medication adherence in an urban U.S. safety-net rheumatology population using the Morisky Medication Adherence Scale (MMAS-8) and PRAPARE, an SDOH screening tool.

Methods: English and Spanish surveys were distributed cross-sectionally to eligible patients after clinic check-in and before their visit. Patients with an RMD were eligible if they had been seen in rheumatology clinic at least once previously and had received RMD-directed treatment for at least 3 months. A subset received only MMAS-8 surveys. A total of 186 MMAS-8 and 74 PRAPARE surveys were analyzed. Demographic and clinical characteristics were collected. Medication adherence was categorized as poor versus medium/high adherence. Intentional and unintentional adherence domains were analyzed separately. Demographic, clinical, medication, and SDOH variables were compared between adherence groups. Surveys were distributed opportunistically during clinic flow; patients approached were not reliably captured, and the analyzed sample represented approximately 15% of the estimated eligible clinic census.

Results: Patient sample data is shown in Table 1. Overall, better medication adherence was associated with older age (mean 53.4 vs 47.5 years, p=0.010) and primary Spanish language preference (77.7% vs 52.9%, p< 0.001) (Table 2). Domain-specific analyses suggested that these associations reflected distinct adherence patterns: older age was associated with better intentional adherence (mean 52.8 vs 47.1 years, p=0.023), whereas primary Spanish language preference was associated with fewer unintentional nonadherence behaviors (77.5% vs 50.0%, p< 0.001). Transportation difficulty was the clearest PRAPARE-derived SDOH variable associated with poor adherence (33.3% vs 9.8%, p=0.042), whereas the overall PRAPARE social-risk score was not associated with adherence. Poor adherence was also more common among patients with systemic lupus erythematosus (34.3% vs 18.8%, p=0.029). Most other RMDs, sex, ethnicity, medication classes, and PRAPARE-derived SDOH variables were not associated with adherence.

Conclusion: Older age and primary Spanish language preference were associated with improved medication adherence, with distinct relationships observed for intentional and unintentional adherence domains. Transportation difficulty emerged as the most actionable SDOH factor associated with poor adherence, suggesting that clinic-based adherence interventions may benefit from targeting specific, modifiable barriers rather than relying on composite social-risk measures alone. Given the exploratory design, self-reported adherence measures, PRAPARE missingness, and lack of multivariable adjustment, these findings should be considered hypothesis-generating.

Supporting image 1Table 1.Demographic, Clinical, and Medication Characteristics of Study Participants (N=186)

Supporting image 2Table 2. Factors Associated with Medication Adherence


Disclosures: V. Esparza: None; N. Samandari: None; P. Zandinejad: None; M. Elbathani: None; A. Leal Bramasco: None; T. Pickering: None; L. Wise: AstraZeneca, 12,, Aurinia, 12,, GlaxoSmithKlein(GSK), 12,.

To cite this abstract in AMA style:

Esparza V, Samandari N, Zandinejad P, Elbathani M, Leal Bramasco A, Pickering T, Wise L. Medication Adherence in an Urban Safety-Net Rheumatology Clinic: Associations with Social Determinants and Clinical Factors [abstract]. Arthritis Rheumatol. 2026; 78 (suppl 9). https://acrabstracts.org/abstract/medication-adherence-in-an-urban-safety-net-rheumatology-clinic-associations-with-social-determinants-and-clinical-factors/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/medication-adherence-in-an-urban-safety-net-rheumatology-clinic-associations-with-social-determinants-and-clinical-factors/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology